Topics: Oncology Quiz
SW is a 66-year-old postmenopausal woman with newly diagnosed metastatic breast cancer to the lung (ER/PR positive; HER2-negative).
Which of the following regimens would be best to treat her cancer at this time?
A. Letrozole plus palbociclib
B. Lapatinib plus capecitabine
C. Trastuzumab
D. Paclitaxel
Preview next quiz:
For patients with moderate-to-severe renal dysfunction, the bone modifying agent of choice is
A. Pamidronate
B. Zoledronic acid
C. Denosumab
D. Calcium carbonate